Envoy to Screen Targets for Takeda Pharmaceutical

Envoy will use its bacTrap technology to search for proteins that are selectively expressed in specific cell types within the brain that are known to be affected in patients with schizophrenia.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories